Year: 2019

MARION, N.C., Dec. 12, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Greene Concepts Inc. (OTCPINK: INKW), (greeneconcepts.com) (“Greene Concepts” or the “Company”) wishes to extend a heartfelt “thank you” to the Greene Concepts shareholders and other interested parties for your continued support. The Company looks forward to you growing with us and will do its best to provide you with open and honest transparency at all times.  Some individuals have asked the Company about the current status of the company and about company actions.  One shareholder even referenced the phrase “transparency nullifies skepticism”. In addition to other press releases, Company filings and disclosures, the Q&A below should assist many whom have had the same or similar questions.  The Company and its CEO Lenny Greene wish to thank each of you...

COMMUNIQUÉ DE PRESSEParis, le 12 décembre 2019Informations relatives au nombre total de droits de vote et d’actionsArticle L. 233-8 II du Code de commerce – Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers* 645 actions auto-détenues privées du droit de vote en vertu de l’article L. 225-210 du Code de commerce au 30 novembre 2019* * *Ce communiqué est disponible sur le site www.sofragi.frSOFRAGI est une société d’investissement à capital fixe (SICAF) ayant la forme d’une société anonyme cotée sur le compartiment C d’Euronext Paris sous le symbole SOFR. Les actions ne peuvent être rachetées par la SICAF à la demande de ses actionnaires.SOFRAGI a réalisé un résultat de – 5 013 560,51 euros pour l’exercice 2018 compte-tenu de l’enregistrement au 31 décembre 2018, en application des dispositions comptables, d’une...

Nasdaq Copenhagen                                                                               Nikolaj Plads 6DK-1067 Copenhagen K   Copenhagen, 12 December 2019STOCK EXCHANGE ANNOUNCEMENT no 12/2019UPGRADE OF THE EXPECTATION FOR 2019The original expectation was DKK 3-4 million for EBIT and a small positive net result before taking into account the valuation of the investment property.Due to higher revenues and lower than expected costs, the company’s management expects that EBIT for 2019 will reach the level of around DKK 6 million and the net result before taking into account the valuation of the investment property of around DKK 3.5 million.EXPECTATION FOR 2020The largest tenant terminated the contract and left at the end of November 2019. Currently, the process of reletting of space which became vacant is in progress. The first...

Nasdaq Copenhagen                                                                               Nikolaj Plads 6DK-1067 Copenhagen K   København, 12. december 2019SELSKABSMEDDELELSE nr. 12/2019OPJUSTEREDE FORVENTNINGER TIL 2019Den oprindelige forventning til EBIT-resultatet var DKK 3-4 mio. og et mindre positivt nettoresultat før indregningen af vurderingen af investeringsejendommen.På grund af en højere omsætning og omkostninger, der var lavere end forventet, forventer selskabets ledelse, at EBIT-resultatet for 2019 vil komme op på ca. DKK 6 mio., og at nettoresultatet før indregningen af vurderingen af investeringsejendommen vil ligge på omkring DKK 3,5 mio.FORVENTNINGER TIL 2020Den største lejer har opsagt sin lejekontrakt og fraflyttede i slutningen af november 2019. For øjeblikket er en proces i gang med at genudleje de nu ledige...

MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Israeli Patent Office has issued BioRestorative a Notice of Allowance on its patent application for a method of generating brown fat stem cells. This is the eighth patent issued, in the United States and other countries, for the Company’s brown fat technology related to BioRestorative’s metabolic program (ThermoStem® Program).Once issued in Israel, the final patent will allow for a method of isolating and differentiating a non-embryonic human brown adipose-derived stem cell into functional human brown adipocytes and a method of identifying compounds that modifies metabolic activity of human brown adipocytes. The technology...

OUTOTEC OYJ   PÖRSSITIEDOTE 12.12.2019 KLO 16.45Outotec Oyj korjaus: Tekninen korjaus 10.12.2019 julkaistun suomenkielisen uuden tulosohjeistuksen sanamuotoonOutotec Oyj:n 10.12.2019 klo 18.21 julkaiseman suomenkielisen pörssitiedotteen kohdasta ”Uusi vuoden 2019 tulosohjeistus jatkuville toiminnoille” puuttuivat sanat ’noin’, ’oikaistu’ ja ’(aEBIT)*’ vuoden 2018 oikaistun liiketuloksen oikaistun luvun yhteydestä. Lisäksi tekstiä on täydennetty IFRS:n mukaiseksi (’lopetetut toiminnot’).Korjattu teksti kokonaisuudessaan:Outotec alentaa vuoden 2019 liikevaihto-ohjeistustaan julkistetun kolmen liiketoiminnan divestointisuunnitelman sekä tiettyjen, jo saatujen ja odotettavissa olevissa tilausten viivästysten takiaOutotecin hallitus on tänään päivittänyt Outotecin vuoden 2019 liikevaihdon ohjeistuksen. Muutoksen aiheuttaa kolmen Metals, Energy...

Til    Nasdaq Copenhagen A/S12. december 2019Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktionerIndberetning og offentliggørelse af ledende medarbejdere og disses nærtstående transaktioner med Nykredit Realkredit A/S værdipapirer i henhold til markedsmisbrugsforordningens artikel 19. Se vedhæftede fil.AttachmentLedende medarbejderes og disses nærtstående transaktioner – Nykredit Realkredit 12122019

ST. LOUIS, Dec. 12, 2019 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that David Kelman has joined the firm as a Managing Director in the Consumer & Retail Group where he will oversee U.S. cannabis investment banking. He is based in New York.Mr. Kelman brings to Stifel more than 20 years of experience in investment banking, private equity, and entrepreneurship. Most recently, he was a Managing Director and Head of Mergers & Acquisitions at Viridian Capital Advisors. While at Viridian, he ran the firm’s M&A practice and was responsible for origination and execution of transactions in the cannabis industry. Prior to Viridian, Mr. Kelman oversaw strategic transactions for a Colorado-based cannabis company with multi-state operations. He also spent nearly a decade at Bear Stearns, DLJ, Credit Suisse,...